Comprehensive Metabolic Panel (CMP) Testing Market By Disease: (Kidney Disease, Liver Disease, Diabetes, Others); By Test Type: (Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose); By End-Use: (Laboratories, PoC) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

Table Of Content

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Comprehensive Metabolic Panel (CMP) Testing
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Comprehensive Metabolic Panel (CMP) Testing Market By Disease
     1.2.2.1. Global Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate Comparison By Disease (2015-2026)
     1.2.2.2. Global Comprehensive Metabolic Panel (CMP) Testing Market Revenue Share By Disease in 2018
     1.2.2.3. Kidney Disease
     1.2.2.4. Liver Disease
     1.2.2.5. Diabetes
     1.2.2.6. Others
   1.2.3. Comprehensive Metabolic Panel (CMP) Testing Market By Test Type
     1.2.3.1. Global Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate Comparison By Test Type (2015-2026)
     1.2.3.2. Proteins
     1.2.3.3. Electrolytes
     1.2.3.4. Kidney Tests
     1.2.3.5. Liver Functional Tests
     1.2.3.6. Glucose
   1.2.4. Comprehensive Metabolic Panel (CMP) Testing Market By End-Use
     1.2.4.1. Global Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate Comparison By End-Use (2015-2026)
     1.2.4.2. Laboratories
     1.2.4.3. PoC
   1.2.5. Comprehensive Metabolic Panel (CMP) Testing Market By Geography
     1.2.5.1. Global Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
     1.2.5.2. North America Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate (2015-2026)
     1.2.5.3. Europe Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate (2015-2026)
     1.2.5.4. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate (2015-2026)
     1.2.5.5. Latin America Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate (2015-2026)
     1.2.5.6. Middle East and Africa (MEA) Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Comprehensive Metabolic Panel (CMP) Testing Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Comprehensive Metabolic Panel (CMP) Testing Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Comprehensive Metabolic Panel (CMP) Testing Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Comprehensive Metabolic Panel (CMP) Testing Major Manufacturers in 2018

CHAPTER 4. COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY DISEASE

4.1. Global Comprehensive Metabolic Panel (CMP) Testing Revenue By Disease
4.2. Kidney Disease
   4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Liver Disease
   4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Diabetes
   4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Others
   4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY TEST TYPE

5.1. Global Comprehensive Metabolic Panel (CMP) Testing Revenue By Test Type
5.2. Proteins
   5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Electrolytes
   5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Kidney Tests
   5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Liver Functional Tests
   5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Glucose
   5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY END-USE
6.1. Global Comprehensive Metabolic Panel (CMP) Testing Revenue By End-Use
6.2. Laboratories
   6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. PoC
   6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY COUNTRY
7.1. North America Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Comprehensive Metabolic Panel (CMP) Testing Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
   7.3.1. U.S. Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   7.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   7.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.4. Canada
   7.4.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   7.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   7.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY COUNTRY
8.1. Europe Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Comprehensive Metabolic Panel (CMP) Testing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
   8.3.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   8.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   8.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.4. Germany
   8.4.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   8.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   8.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.5. France
   8.5.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   8.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   8.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.6. Spain
   8.6.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   8.6.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   8.6.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.7. Rest of Europe
   8.7.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   8.7.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   8.7.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY COUNTRY
9.1. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
   9.3.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   9.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   9.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.4. Japan
   9.4.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   9.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   9.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.5. India
   9.5.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   9.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   9.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.6. Australia
   9.6.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   9.6.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   9.6.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.7. South Korea
   9.7.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   9.7.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   9.7.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
   9.8.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   9.8.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   9.8.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY COUNTRY
10.1. Latin America Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Comprehensive Metabolic Panel (CMP) Testing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
   10.3.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   10.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   10.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.4. Mexico
   10.4.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   10.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   10.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.5. Rest of Latin America
   10.5.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   10.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   10.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY COUNTRY
11.1. Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
   11.3.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   11.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   11.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
11.4. South Africa
   11.4.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   11.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   11.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
11.5. Rest of Middle East & AFRICA
   11.5.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
   11.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
   11.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Sonic Healthcare
   12.1.1. Company Snapshot
   12.1.2. Overview
   12.1.3. Financial Overview
   12.1.4. Type Portfolio
   12.1.5. Key Developments
   12.1.6. Strategies
12.2. Quest Diagnostics
   12.2.1. Company Snapshot
   12.2.2. Overview
   12.2.3. Financial Overview
   12.2.4. Type Portfolio
   12.2.5. Key Developments
   12.2.6. Strategies
12.3. UNIPATH
   12.3.1. Company Snapshot
   12.3.2. Overview
   12.3.3. Financial Overview
   12.3.4. Type Portfolio
   12.3.5. Key Developments
   12.3.6. Strategies
12.4. Laboratory Corporation of America Holdings (LabCorp)
   12.4.1. Company Snapshot
   12.4.2. Overview
   12.4.3. Financial Overview
   12.4.4. Type Portfolio
   12.4.5. Key Developments
   12.4.6. Strategies
12.5. Abbott
   12.5.1. Company Snapshot
   12.5.2. Overview
   12.5.3. Financial Overview
   12.5.4. Type Portfolio
   12.5.5. Key Developments
   12.5.6. Strategies
12.6. SYNLAB International GmbH
   12.6.1. Company Snapshot
   12.6.2. Overview
   12.6.3. Financial Overview
   12.6.4. Type Portfolio
   12.6.5. Key Developments
   12.6.6. Strategies
12.7. Others
   12.7.1. Company Snapshot
   12.7.2. Overview
   12.7.3. Financial Overview
   12.7.4. Type Portfolio
   12.7.5. Key Developments
   12.7.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
   13.1.1. Initial Data Search
   13.1.2. Secondary Research
   13.1.3. Primary Research
13.2. Assumptions and Scope


Cart Summary